Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. Its boronic acid functionality enables participation in Suzuki-Miyaura cross-coupling reactions, allowing for efficient formation of carbon-carbon bonds in complex molecule assembly. Commonly employed in medicinal chemistry for structure-activity relationship studies due to the stability and reactivity of the boronic acid group. The tert-butoxycarbonyl (Boc) protecting group enhances solubility and stability during reaction sequences, making it suitable for multi-step syntheses. Frequently utilized in the preparation of drug candidates targeting cancer, inflammation, and central nervous system disorders.